http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108823144-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-999 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-25 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-069 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-44 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2018-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108823144-B |
| titleOfInvention | Inhibit the excretion body active ingredient and its preparation method and application of endothelial cell migration |
| abstract | The present invention relates to a kind of excretion body active ingredients and its preparation method and application for inhibiting endothelial cell migration, and preparation method is the following steps are included: separating primary umbilical vein endothelial cell and carrying out cell culture and passage；Anisodamine Human Umbilical Vein Endothelial Cells are added into the culture fluid of endothelial cell of secondary culture to be pre-processed, simultaneously TNF-α continuation Cultured endothelial cell is added in the culture fluid of endothelial cell then more renewed；Excretion body is extracted in the culture fluid of endothelial cell containing TNF-α obtained from after Endothelial cell culture；The identification of excretion body.With the excretion body active ingredient prepared by preparation method of the present invention for inhibiting endothelial cell migration and its application in anti-tumor drug.Preparation method of the present invention is simple, and the excretion body of preparation is able to suppress the migration of endothelial cell. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112029705-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112029705-A |
| priorityDate | 2018-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.